Katalóg evidencie publikačnej činnosti PU

ID záznamu:	58031
Kategória:	ADM
Autor:	Berger Thomas (1%)
Autor:	Adamczyk-Sowa Monika (1%)
Autor:	Csépány Tünde (1%)
Autor:	Fazekas Franz (1%)
Autor:	Hojs Fabjan Tanja (1%)
Autor:	Horáková Dana (1%)
Autor:	Illes Zsolt (1%)
Autor:	Klímová Eleonóra (30%)
Autor:	Leutmezer Fritz (1%)
Autor:	Rejdak Konrad (1%)
Autor:	Rozsa Csilla (1%)
Autor:	Šega Jazbec Saša (1%)
Autor:	Szilasiová Jarmila (30%)
Autor:	Turčáni Peter (26%)
Autor:	Vachová Marta (1%)
Autor:	Vécsei László (1%)
Autor:	Havrdová Eva (1%)
Názov:	Management of multiple sclerosis patients in central European countries: current needs and potential solutions [elektronický dokument]
Zdroj:	Therapeutic Advances in Neurological Disorders [print, elektronický dokument]
Lokácia:	Roč. 11. - London, (2018), s. 1-12
ISSN:	1756-2856. - ISSN 1756-2864
URL:	https://www.scopus.com/record/display.uri?eid=2-s2.0-85054862551&origin=resultslist
Ohlas:	[1] 2019. KAPICA-TOPCZEWSKA, Katarzyna, TARASIUK, Joanna, COLLIN, Francois et al. The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population. In PLoS One : elektronický dokument, ISSN 1932-6203. San Francisco, 2019, Roč. 14, č. 10. SCO ; WOS CC.
Ohlas:	[1] 2021. BOYKO, Alexey, THERAPONTOS, Christina, HORÁKOVÁ, Dana et al. Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals. In Multiple Sclerosis and Related Disorders : print, elektronický dokument, ISSN 2211-0348; 2211-0356. Oxon, 2021, Roč. 50, s. 1-12. Dostupný na internete <https://www.scopus.com/record/display.uri?eid=2-s2.0-85100764872&origin=resultslist&sort=plf-f&src=s&st1=&st2=&sid=86cb1f72d0aac54b4c1a648f260f8341&sot=b&sdt=b&sl=188&s=TITLE-ABS-KEY+%28Approaches+and+challenges+in+the+diagnosis+and+management+of+secondary+progressive+multiple+sclerosis%3a+A+Central+Eastern+European+perspective+from+healthcare+professionals.%29&relpos=0&citeCnt=0&searchTerm=>
Ohlas:	[1] 2020. KAPICA-TOPCZEWSKA, Katarzyna, COLLIN, Francois, TARASIUK, Joanna et al. Clinical and epidemiological characteristics of multiple sclerosis patients receiving disease-modifying treatment in Poland. In Neurologia i Neurochirurgia Polska : print, ISSN 0028-3843; 1897-4260. Wroclaw, 2020, Roč. 54, č. 2, 161-168.
Ohlas:	[1] 2018. GHEZZI, Angelo. European and American guidelines for multiple sclerosis treatment. In Neurology and therapy : print, elektronický dokument, ISSN 2193-8253; 2193-6536. New York, 2018, Roč. 7, č. 2, 189-194.
Ohlas:	[1] 2020. BERGER, Thomas, ADAMCZYK-SOWA, Monika, CSÉPÁNY, Tünde et al. Factors influencing daily treatment choices in multiple sclerosis. In Therapeutic Advances in Neurological Disorders : print, elektronický dokument, ISSN 1756-2856; 1756-2864. London, 2020, Roč. 13, s. 1-13. Dostupný na internete <http://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=3&SID=F5luw8XNhvfyBQLjfR1&page=1&doc=1>
Ohlas:	[1] 2021. ORLEWSKA, Katarzyna, BOGUSZ, Krzysztof, PODLECKA-PIęTOWSKA, Aleksandra et al. Impact of immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) on treatment cost of multiple sclerosis: real-world nationwide study. In Value in Health Regional Issues : elektronický dokument, ISSN 2212-1099. 2021, Roč. 25, 104-107.
Ohlas:	[1] 2019. HORÁKOVÁ, Dana, ROČKOVÁ, Petra, JIRČÍKOVÁ, Jitka et al. Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS. In Multiple Sclerosis and Related Disorders : print, elektronický dokument, ISSN 2211-0348; 2211-0356. Oxon, 2019, Roč. 35, s. 196-202.
Ohlas:	[1] 2020. MOHAMMADZADEH, Niloofar, GHAZANFARISAVADKOOHI, Ehsan, KHENARINEZHAD, Sahar et al. Requirements of the national multiple sclerosis disease registry system: A review of experiences. In Gazi Medical Journal : elektronický dokument, ISSN 2147-2092. Ankara, 2020, Roč. 32, č. 1, 154-160.
Ohlas:	[1] 2019. COYLE, Patricia K., KHATRI, Bhupendra, EDWARDS, Keith R. et al. Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study. In Multiple Sclerosis and Related Disorders : print, elektronický dokument, ISSN 2211-0348; 2211-0356. Oxon, 2019, Roč. 31, 157-164.
Ohlas:	[1] 2020. MORAL TORRES, Ester, FERNÁNDEZ FERNÁNDEZ, Óscar, CARRASCAL RUEDA, Pedro et al. Social value of a set of proposals for the ideal approach of multiple sclerosis within the Spanish National Health System: A social return on investment study. In BMC health services research : elektronický dokument, ISSN 1472-6963. Londýn, 2020, Roč. 20, č. 1.
Ohlas:	[1] 2021. SEITARIDOU, Yoana, TSEKOV, Ivo, KAMUSHEVA, Maria et al. Analysis of patients’ access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece. In Expert review of pharmacoeconomics and outcomes research : print, elektronický dokument, ISSN 1473-7167; 1744-8379. Abingdon, 2021.
Ohlas:	[1] 2021. WNUK, Marcin, MALUCHNIK, Michal, PERWIENIEC, Jakub et al. Multiple sclerosis incidence and prevalence in Poland: Data from administrative health claims. In Multiple Sclerosis and Related Disorders : print, elektronický dokument, ISSN 2211-0348; 2211-0356. Oxon, 2021, Roč. 55.
Oblasť výskumu:	180